Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

Smoking cessation drugs market

This is a preview of subscription content

Access options

Buy article

Get time limited or full article access on ReadCube.

$32.00

All prices are NET prices.

Figure 1: Leading smoking cessation brands in 2011 and 2016.

References

  1. Visiongain. Smoking Cessation Drugs: World Market Prospects 2012–2022. Visiongain (2012).

  2. World Health Organization (WHO). WHO report on the global tobacco epidemic, 2011: warning about the dangers of tobacco. WHO website [online], (2011).

  3. Stead, L. F. et al. Nicotine replacement therapy for smoking cessation. Cochrane Database Syst. Rev. 2008, CD000146 (2008).

    Google Scholar 

  4. Noble, H. B. New from the smoking wars: success. New York Times [online], (1999).

Download references

Author information

Authors and Affiliations

Authors

Corresponding authors

Correspondence to Basharut A. Syed or Kritika Chaudhari.

Ethics declarations

Competing interests

The authors declare no competing financial interests.

Rights and permissions

Reprints and Permissions

About this article

Cite this article

Syed, B., Chaudhari, K. Smoking cessation drugs market. Nat Rev Drug Discov 12, 97–98 (2013). https://doi.org/10.1038/nrd3914

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/nrd3914

Search

Quick links

Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing